Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2003
11/26/2003EP1364005A2 A method for evolving a cell having desired phenotype and envolved cells
11/26/2003EP1364002A2 Process for the preparation of neutrophil inhibitory factor
11/26/2003EP1363998A1 Novel human poly(a)polymerase gamma (pap gamma)
11/26/2003EP1363997A1 Concentration and lysis of adenovirus-infected cells in a single unit operation
11/26/2003EP1363996A2 Epothilone resistant cell lines
11/26/2003EP1363995A2 Use of a composition with antioxidant activity for conditioning stem cells
11/26/2003EP1363994A2 Thymic epithelial progenitor cells and uses thereof
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363961A2 End group activated polymers with oligonucleotide ligands
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363941A2 Histidine phosphatase interacting protein of 120 kd
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363936A1 Juvenile hormone esterase
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363924A1 Avilamycin derivatives
11/26/2003EP1363685A2 Connective tissue substitutes, method of preparation and uses thereof
11/26/2003EP1363657A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/26/2003EP1363551A1 Implant with access channels
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP0871492B1 Mesothelium antigen and methods and kits for targeting it
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458973A Pre-adipose cell lines
11/26/2003CN1458273A Separating preparing and use of human fetal dorsal root ganglionic stem cell
11/26/2003CN1458271A Microbe and cell liquid cultivating method and its cultivating device
11/26/2003CN1457634A Mouse model of hipatitis B virus gene positioning integration to result in liver cell callcer
11/26/2003CN1128878C Coding sequence of human methionine sulfoxide rductase, its encoded polypeptide and its preparing method
11/26/2003CN1128876C Transferrin receptor genes of moraxella
11/25/2003US6653533 Vectors comprising foreign nucleotide sequence; transcription factors that enhance activation of defense mechanisms
11/25/2003US6653529 Transforming monocotyledon cells with nucleic acid constructs linked to promoters, then culturing in imazethapyr, imazameth, imazapyr, imazamox or imazaquin, to form hydrids having herbicide resistance
11/25/2003US6653526 Transgenic mice exhibiting increased susceptibility to seizures
11/25/2003US6653459 Isolated nucleic acid encoding a polypeptide of given sequence; use in producing glycoproteins with minimal and uniform sugar residues; low antigenicity; side-effect reduction of drugs
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653447 ULBP DNA and polypeptides
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653445 Chemotactic cytokine V (CCV); isolated protein of given sequence; use in diagnostics and as anti-viral or anti-tumor agent
11/25/2003US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653280 Antifungal polypeptide AlyAFP from Alyssum and methods for controlling plant pathogenic fungi
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6653132 IRES sequences with high translational efficiency and expression vectors containing the sequence
11/25/2003US6653131 Method of treating systemic inflammatory response syndrome
11/25/2003US6653130 Method for the development of an HIV vaccine
11/25/2003US6653129 Method for isolation of cells from a solution
11/25/2003US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
11/25/2003US6653105 For production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6653101 Transforming a eukaryotic host by transfection with transcription units containing genes encoding a transactivator; promoters; use for increasing amount of protein expressed
11/25/2003US6653089 Generating flowing fluid against surface of cell; obtain cell, incubate with binding agent, monitor position of binding agent in cell
11/25/2003US6653068 Generation of specific binding partners binding to (poly)peptides encoded by genomic DNA fragments or ESTs
11/25/2003US6653063 Nutrient broth for use in maintaining preferential cell viability and shelf life
11/25/2003US6652872 Support for the propagation of preferential tissues
11/25/2003US6652851 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
11/25/2003US6652850 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
11/25/2003US6652848 Dendritic cell hybrids
11/25/2003CA2194166C Multi-stage cascase boosting vaccine
11/25/2003CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
11/25/2003CA2083837C Recombinant dna coding for a novel protein having .beta.-1,3 glucanase activity, bacteria containing this dna, transformed plant cells and plants
11/25/2003CA2053230C Potato .alpha. -amylase genes
11/20/2003WO2003095982A1 Wavy interface mixer
11/20/2003WO2003095976A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095656A1 Recombinant fowlpox virus
11/20/2003WO2003095649A1 Nobel glyphosate-tolerant 5-enolpyruvylshikimate-3-phospha synthase and gene encoding it
11/20/2003WO2003095641A1 Intracellular protein delivery compositions and methods of use
11/20/2003WO2003095634A1 Pax-5-deficient pro-b-cells, methods of producing them and the use of such cells in human therapy
11/20/2003WO2003095633A2 Method for the production of cells with increased development potential
11/20/2003WO2003095632A1 Method and system for obtaining cells of specific type from biological material
11/20/2003WO2003095631A1 Method for establishing and expanding multipotent stem cells
11/20/2003WO2003095630A2 Bioartificial skin comprising genetically modified fibroblasts
11/20/2003WO2003095629A1 Production of neural progenitor cells
11/20/2003WO2003095628A2 Control of es cell self renewal and lineage specification, and medium therefor
11/20/2003WO2003095605A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
11/20/2003WO2003095603A1 Cell culture system
11/20/2003WO2003095449A1 Small molecules for inhibition of function and drug delivery to leukocytes
11/20/2003WO2003095359A2 Nanotube mat with an array of conduits
11/20/2003WO2003095016A1 System and method for forming a non-ablative cardiac conduction block
11/20/2003WO2003094965A2 Modulation of neural stem cells with s1p or lpa receptor agonists
11/20/2003WO2003094958A1 Immunoprotective methods for beta cell neogenesis
11/20/2003WO2003094953A1 Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094857A2 Stimulation by toll-like receptors inhibits osteoclast differentiation
11/20/2003WO2003094855A1 System and method for treating cardiac arrhythmias with fibroblast cells
11/20/2003WO2003094600A1 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content
11/20/2003WO2003084479A3 Large scale methods of producing adenovirus and adenovirus seed stocks
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003051927A3 Production of f(ab')2 fragments in mammalian cells
11/20/2003WO2003050287A3 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
11/20/2003WO2003046124A3 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
11/20/2003WO2003042401A3 Novel chromophores/fluorophores and methods for using the same
11/20/2003WO2003042360A3 Antisense modulation of inhibitor-kappa b-r expression
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 1827